Rakuten Securities’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Rakuten Securities's CYTK Position: Q3 2026 in Review
Rakuten Securities opened a new position in Cytokinetics (CYTK) in Q3 2026: 70 shares worth $4.61K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in CYTK as recently as Q1 2026.
Rakuten Securities first reported a position in CYTK in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.2K in Q1 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Rakuten Securities held 70 shares of Cytokinetics worth $4.61K as of Q3 2026.
- Cytokinetics was a new Rakuten Securities position in Q3 2026.
- Cytokinetics made up ﹤0.01% of Rakuten Securities's portfolio in Q3 2026, its #615 holding.
- Rakuten Securities first reported a position in Cytokinetics in Q4 2025 and has held it in 3 quarters since.
- Rakuten Securities's Cytokinetics position peaked at $11.2K in Q1 2026.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.